Inventor · disambiguated record
Xing'Er Christine Koo
Also filed as: KOO XING'ER CHRISTINE
6 granted patents·2 pending applications·15 citations·filing 2017–2025
77Inventor score
Files withCHUGAI PHARMACEUTICAL CO LTD8
Top patents by PatentIndex Score
8 records- 0193US10604561B2Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2017·Granted Mar 31, 2020·11 cites·15 claims
- 0292US12187786B2Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Granted Jan 7, 2025·1 cites·1 claims
- 0384US11312767B2Cross-species anti-latent TGF-beta 1 antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Granted Apr 26, 2022·1 cites·19 claims
- 0484US10844113B2Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted Nov 24, 2020·2 cites·11 claims
- 0575US2025313617A1Cross-species anti-latent tgf-beta 1 antibodies and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 0672US11780908B2Anti-dengue virus antibodies, polypeptides containing variant FC regions, and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Granted Oct 10, 2023·0 cites·6 claims
- 0771US12371483B2Cross-species anti-latent TGF-beta 1 antibodies and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Granted Jul 29, 2025·0 cites·26 claims
- 0871US2024190948A1Anti-dengue virus antibodies having cross-reactivity to zika virus and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xing'Er Christine Koo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →